Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,163,711
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
38,437,133
-
Shares change
-
+3,422,453
-
Total reported value, excl. options
-
$121,095,668
-
Value change
-
-$70,697,347
-
Put/Call ratio
-
0%
-
Number of buys
-
39
-
Number of sells
-
-52
-
Price
-
$3.15
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q4 2018
116 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q4 2018.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,437,133 shares
.
Largest 10 shareholders include RTW INVESTMENTS, LP (6,256,840 shares), BlackRock Inc. (4,443,970 shares), RENAISSANCE TECHNOLOGIES LLC (3,717,767 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3,000,000 shares), JPMORGAN CHASE & CO (2,926,332 shares), DIMENSIONAL FUND ADVISORS LP (1,768,246 shares), Vanguard Group Inc (1,647,069 shares), CITADEL ADVISORS LLC (1,515,207 shares), WS MANAGEMENT LLLP (1,285,400 shares), and EVENTIDE ASSET MANAGEMENT, LLC (1,146,580 shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.